US Patent Issued to NUVATION BIO on Jan. 28 for "Anti-cancer nuclear hormone receptor-targeting compounds" (American, Indian, Canadian Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,141, issued on Jan. 28, was assigned to NUVATION BIO INC. (New York).

"Anti-cancer nuclear hormone receptor-targeting compounds" was invented by David Hung (New York), Son Minh Pham (San Francisco), Sarvajit Chakravarty (Edmond, Okla.), Jiyun Chen (Moraga, Calif.), Jayakanth Kankanala (Plymouth, Minn.), Jeremy D. Pettigrew (Burnaby, Canada), Anup Barde (Uttar Pradesh, India) and Anjan Kumar Nayak (Uttar Pradesh, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to anti-cancer compounds derived from nuclear steroid receptor binders, to products containing the same, as well as to methods of their use and preparation."

The pa...